Request for Information: Training and Care Delivery Models for Safe Administration of Potential FDA-Approved Psychedelic Therapies in Ambulatory Clinical Settings
Details
The document's own metadata, straight from the source system.
- Title
- Request for Information: Training and Care Delivery Models for Safe Administration of Potential FDA-Approved Psychedelic Therapies in Ambulatory Clinical Settings
On April 18, 2026, President Trump issued Executive Order (EO) 14401, “Accelerating Medical Treatments for Serious Mental Illness”, acknowledging that individuals suffering from serious mental illness may not always respond to existing therapies. This request for information (RFI) solicits stakeholder feedback on training and care delivery models that could be used to ensure safe and effective delivery of potential future Food and Drug Administration (FDA)-approved psychedelic drugs, including drugs administered in ambulatory clinic settings, such as health centers and rural health clinics.
- Posted
- Jul 14, 2026
- Comment period
- Jul 14, 2026 – Aug 14, 2026
- FR Doc
- 2026-14146
Overview
No comments yet — comment period open · 30 days left.
Explorer
Every mirrored comment — filter by stance, campaign, or issue.
No comments match.